← All organizations
Highest phase reached
Phase 4
Timeline
1990s
- Jan 1, 1991
CASI Pharmaceuticals, Inc.— Founded
2010s
- Nov 22, 2013
repaglinide— Marketing Organization
Drugs by trial phase (11 distinct, 24 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Endometrial Neoplasms
- Glioblastoma
- Lung Neoplasms
- Metaplasia
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Preleukemia
- Primary Myelofibrosis
- Prostatic Neoplasms
- Triple Negative Breast Neoplasms
Marketed drugs (24)
Recent trials (29)
- NCT07017725Lead sponsorPhase 1/Phase 2Jan 3, 2025
- NCT05438394CollaboratorPhase 1Oct 13, 2022
- NCT04758767Lead sponsorPhase 1Mar 22, 2021
- NCT04758767Study directorPhase 1Mar 22, 2021
- NCT06425276Lead sponsorPhase 4Jul 24, 2020
- NCT02234986Study directorPhase 2Oct 1, 2015
- NCT02234986Lead sponsorPhase 2Oct 1, 2015
- NCT01639248Study directorPhase 2Jul 1, 2012
- NCT01639248Lead sponsorPhase 2Jul 1, 2012
- NCT01104675Lead sponsorPhase 2Apr 1, 2010
- NCT01104675Study directorPhase 2Apr 1, 2010
- NCT00904787Lead sponsorPhase 1Apr 1, 2009
- NCT00806065Lead sponsorPhase 1Dec 1, 2008
- NCT00658671Lead sponsorPhase 1Apr 1, 2008
- NCT00658671Study directorPhase 1Apr 1, 2008
Details
- Founded
- Rockville, MD, US Jan 1, 1991
- Last known activity
- Jan 3, 2025